Copeptin
Copeptin is a surrogate marker for vasopressin and is used to assess cardiovascular stress and prognosis in patients with cardiovascular diseases.
Copeptin is a prognostic biomarker for cardiovascular stress and outcomes.
Key facts at a glance
- Units
- pmol/L
- Clinical utility
- prognostic
- Result kind
- quantitative
- FDA-cleared
- Roche Copeptin, Brahms Copeptin
Copeptin is a 39-amino acid glycopeptide that is released in equimolar amounts with vasopressin (also known as antidiuretic hormone) from the posterior pituitary gland. It serves as a stable and easily measurable surrogate marker for vasopressin levels.
In the context of cardiovascular diseases, elevated copeptin levels indicate increased cardiovascular stress and have been associated with adverse outcomes such as heart failure, myocardial infarction, and mortality.
Measuring copeptin levels can help clinicians assess the prognosis of patients with cardiovascular conditions and guide treatment decisions to improve patient outcomes.
Frequently asked questions
What is the normal range for copeptin levels?
How is copeptin measured?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy